UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000001539
Receipt No. R000001862
Scientific Title Phase II trial of taxane compound and carboplatin in stage Ib-II uterine cervical nonsqumous cell carcinoma with risk factors
Date of disclosure of the study information 2009/01/01
Last modified on 2021/04/13 21:15:24

No. Disposal Last modified on Item of update
1 Insert 2008/12/02 11:23:56
2 Update 2009/11/18 21:10:47 UMIN ID1
3 Update 2009/11/18 21:26:05 Recruitment status
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
4 Update 2011/03/04 10:41:40 Organization
Address
Organization
Name of person sending information
Organization
Division name
Address
5 Update 2011/03/04 10:42:36 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
6 Update 2013/07/29 20:08:58 Post marketing survey by drug manufacture etc., specified by Japanese law.
7 Update 2014/05/02 12:08:41 Last name of lead principal investigator
TEL
Email
Last name of contact person
Last name of contact person
Address
Address
TEL
Email
8 Update 2014/07/02 21:18:38 Recruitment status
9 Update 2015/09/30 10:24:09 Recruitment status
10 Update 2021/04/13 21:11:04 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Name of primary sponsor
Organization
Organization
Organization
Address
Address
Tel
Email
11 Update 2021/04/13 21:13:10 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
12 Update 2021/04/13 21:15:24 Recruitment status
Date of IRB
Other related information
Other related information


Contact us.